Bank Of America Corp Indaptus Therapeutics, Inc. Transaction History

Bank Of America Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$0.55 - $0.98 $20 - $36	37 Added 60.66%	98 $0
Q4 2024 Feb 14, 2025	BUY	$0.84 - $1.77 $0 - $1	1 Added 1.67%	61 $0
Q3 2024 Nov 14, 2024	BUY	$1.13 - $2.25 $20 - $40	18 Added 42.86%	60 $0
Q2 2024 Aug 14, 2024	BUY	$2.0 - $2.8 $84 - $117	42 New	42 $0
Q4 2023 Feb 14, 2024	BUY	$1.75 - $2.75 $5 - $8	3 New	3 $0
Q4 2022 Feb 10, 2023	BUY	$1.37 - $2.19 $15 - $24	11 New	11 $0

214K

Ticker INDP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,258,600
Market Cap $68.1M
Description
Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.